Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07212114 · ClinicalTrials.gov registry record · Phase 3
Efficacy of EXPAREL vs. Bupivacaine
A Phase 3 study of Total Ankle Arthroplasty and Postsurgical Analgesia, sponsored by Emory University.
- Recruiting
- Registry status
- Phase 3
- Development phase
- 104
- Enrollment target
- 1
- Study location
NCT07212114 is a Phase 3 study of Total Ankle Arthroplasty and Postsurgical Analgesia that is actively recruiting participants, run by Emory University. The registered enrollment target is 104 participants. The trial reports 1 study location across 1 state.
The verdict
NCT07212114, a Phase 3 study of Total Ankle Arthroplasty and Postsurgical Analgesia, is actively recruiting participants, sponsored by Emory University.
- RECRUITING
- Registry status
- Phase 3
- Development phase
- 104 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this clinical study is to learn about pain management strategies in subjects undergoing total ankle replacement. arthroplasty surgery The primary objective is to compare the magnitude of the analgesic effect following a single dose injection of EXPAREL vs. 0.25% bupivacaine (HCl). Secondary objectives are to: Compare the total opioid consumption (in oral morphine equivalents) from 0 to 96 hours following a single dose injection of EXPAREL vs. 0.25% bupivacaine HCl * Compare the time to first opioid consumption following a single dose injection of EXPAREL vs. 0.25% bupivacaine HCl * Assess the safety of EXPAREL vs. 0.25% bupivacaine HCl * Evaluate subject satisfaction with pain management following a single-dose injection of EXPAREL vs. 0.25% bupivacaine hydrochloride (HCl) * Compare clinical performance from Preoperative status to 3- and 12- months postoperatively
Conditions Studied
Interventions
- DRUG EXPAREL
- DRUG 0.25% bupivacaine (HCl): 50 ml
- DRUG 0.25% bupivacaine (HCl): 30 ml
Study Locations (1)
Georgia
- Emory University Orthopaedic Hospital Musculoskeletal Institute (MSK) - Atlanta
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 104 participants |
| Start Date | 2025-11-17 |
| Est. Completion | 2029-08 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07212114
The ClinicalTrials.gov registry entry for NCT07212114 describes a study currently listed as recruiting, categorized as Phase 3. The registered enrollment target is 104 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Emory University, which has 1,208 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Total Ankle Arthroplasty appearing as the primary indexed condition, and to 3 interventions - of which EXPAREL is the first listed.
NCT07212114 reports 1 study location spanning 1 distinct geographic area - top geographies include Georgia.
Frequently Asked Questions
What is clinical trial NCT07212114 about?
NCT07212114 is a clinical study titled "Efficacy of EXPAREL vs. Bupivacaine". The goal of this clinical study is to learn about pain management strategies in subjects undergoing total ankle replacement. arthroplasty surgery The primary objective is to compare the magnitude of the analgesic effect following a single dose injection of EXPAREL vs. 0.25% bupivacaine (HCl). Secon...
What is the current status of trial NCT07212114?
This trial is currently recruiting. It is a Phase 3 study. The enrollment target is 104 participants. The study started on 2025-11-17. Estimated completion is 2029-08.
What conditions does trial NCT07212114 study?
This clinical trial studies the following conditions: Total Ankle Arthroplasty, Postsurgical Analgesia.
What interventions are being tested in trial NCT07212114?
The interventions under investigation include: EXPAREL (DRUG), 0.25% bupivacaine (HCl): 50 ml (DRUG), 0.25% bupivacaine (HCl): 30 ml (DRUG).
Who is sponsoring clinical trial NCT07212114?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07212114 being conducted?
This trial has 1 study location across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Total Ankle Arthroplasty
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.